Vijay H. Shah, MD, FAASLD

Vijay H. Shah, MD, FAASLD received his undergraduate, medical, and clinical medicine training at Northwestern University. He obtained advanced clinical and research postdoctoral fellowship training in hepatology and portal hypertension at Yale University.

He has maintained an NIH-funded program at Mayo Clinic for almost 25 years which focuses broadly on alcohol-associated liver disease, cirrhosis, portal hypertension and its complications with over 250 peer-reviewed publications in prestigious journals such as Journal of Clinical Investigation, Nature, Proceedings of National Academy of Science, New England Journal of Medicine and others.

Dr. Shah is a member of the prestigious American Society of Clinical Investigation and the American Associations of Physicians. Presently, Dr. Shah serves as the Charles M. Gatton and Mayo Distinguished Investigator Chair of Medicine at Mayo Clinic.

Disclosures of Potential Conflicts of Interest
Dr. Vijay H. Shah is an Advisory Board Member for Azaka Bioscience Ltd. and Surrozen Inc., provides consulting services for Ambys Medicine and Durect Corporation, and has a know-how arrangement with Generon Shanghai processed through Mayo Clinic.